Selected article for: "ART vaccine and population level"

Author: Metzger, Vincent T.; Lloyd-Smith, James O.; Weinberger, Leor S.
Title: Autonomous Targeting of Infectious Superspreaders Using Engineered Transmissible Therapies
  • Document date: 2011_3_17
  • ID: 0gt21051_16
    Snippet: These results are not intended to argue that ART campaigns be abandoned or vaccine trials be halted. On the contrary, as we show below, the TIP's ability to target high-risk groups allows the TIP to complement ART (or vaccine) campaigns and significantly enhance the population-level efficacy of these approaches......
    Document: These results are not intended to argue that ART campaigns be abandoned or vaccine trials be halted. On the contrary, as we show below, the TIP's ability to target high-risk groups allows the TIP to complement ART (or vaccine) campaigns and significantly enhance the population-level efficacy of these approaches.

    Search related documents:
    Co phrase search for related documents
    • high risk and population level efficacy: 1
    • high risk and vaccine trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • high risk group and population level: 1, 2, 3, 4, 5
    • high risk group and vaccine trial: 1, 2, 3
    • population level and vaccine trial: 1, 2, 3, 4
    • population level efficacy and vaccine trial: 1